Aimed Bio Inc.
Overview
Aimed Bio Inc., founded in 2018 as a spin-off from Samsung Medical Center, is a biotechnology company specializing in antibody-drug conjugates (ADCs) and bispecific antibodies. The company integrates patient-derived data throughout its development process to enhance precision and clinical relevance in cancer therapies.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Aimed Bio Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Aimed Bio Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.